Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session on Growth Update - Case Based Approach to short stature
A case-based approach to managing short stature provides a comprehensive framework for understanding and addressing the condition in pediatric patients. Short stature, defined as a height significantly below the average for a child's age and sex, can be caused by a variety of genetic, hormonal, and environmental factors. This approach involves detailed case evaluations to identify the underlying causes and determine the most appropriate interventions.
The first step in a case-based approach is a thorough evaluation of the patient’s medical history, growth patterns, and physical examination findings. Key assessments include growth charts, familial height patterns, and screening for chronic illnesses or nutritional deficiencies. Hormonal evaluations and genetic testing may also be necessary to pinpoint specific causes, such as growth hormone deficiencies or genetic syndromes.
Tailored treatment plans ensure that each patient receives the most effective and targeted intervention based on their unique condition and needs.
Therefore, get an overall knowledge of growth update - case based approach to short stature
See More Webinars @ Hidoc Webinars
1.
While most cancer screenings won't prolong lives, there are still good reasons to continue screening.
2.
High Fruit, Veggie Diet Tied to Early-Onset Lung Cancer?
3.
Cancer Diagnoses Slow to Recover From Effects of COVID Pandemic
4.
The pandemic had little impact on mental health symptoms.
5.
How breast tissue density affects your risk of breast cancer
1.
Uncovering Breast Cancer: The Power of Early Stage Ultrasound
2.
Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning
3.
The Miracle of Tenecteplase: How This Drug Is Saving Lives
4.
Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance
5.
Patient-Centric Approaches in Hematology: Integrating Individualized Care into Modern Clinical Practice
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation